Skip to main content

Bjorn Knollmann Archives

VUMC joins research network to fight atrial fibrillation

Jun. 14, 2018—Vanderbilt University Medical Center (VUMC) has been selected by the American Heart Association (AHA) to participate in a six-member research network to advance treatment and prevention of atrial fibrillation (AFib), an irregular heart rate that increases the risk of stroke and other heart-related complications.

Read more


Six Vanderbilt physicians honored by medical societies

May. 3, 2018—Four faculty members of Vanderbilt University School of Medicine were among 78 physician-scientists inducted into The American Society for Clinical Investigation (ASCI), an elite honor society of physician-scientists from the upper ranks of academic medicine and industry. They are:

Read more


Nine new endowed chair recipients honored

Mar. 5, 2018—Nine Vanderbilt University faculty members named to endowed chairs were honored during a celebration at the Student Life Center Feb. 28.

Read more


Knollmann to direct new arrhythmia research center

Jan. 14, 2016—Björn Knollmann, M.D., Ph.D., has been named director of the newly formed Vanderbilt Center for Arrhythmia Research and Therapeutics (VanCART).

Read more


New method aids heart disease studies, drug discovery efforts

Jan. 14, 2016—A team of Vanderbilt investigators developed a new method for rapidly generating heart muscle cells from stem cells.

Read more


Normalizing calcium flux to treat atrial fibrillation

May. 12, 2014—A particular anti-arrhythmia drug provides a targeted treatment for certain forms of atrial fibrillation.

Read more


Reducing fatal rhythms after heart attack

Jul. 26, 2013—Reducing heart muscle response to calcium could decrease the risk of fatal arrhythmias after heart attacks.

Read more


Green tea for failing hearts?

Nov. 16, 2012—The main antioxidant compound in green tea increases contractile force in isolated heart cells, suggesting it may be useful in heart failure.

Read more


Upcoming Events

MORE EVENTS »